Please provide your email address to receive an email when new articles are posted on . A subset of Hispanic patients within the larger GEMINI study confirmed the good outcomes of combined ...
MENLO PARK, Calif., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences”), an eyecare technology company focused on developing and commercializing innovative ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A study looked at real-world outcomes with Omni, Hydrus, ...
“Given the global patient compliance challenges and eventual limitations inherent in topical IOP-lowering medications, the long-term reduction in both IOP and medication usage for mild, moderate, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback